Cargando…

High Cancer Susceptibility Candidate 8 Expression Is Associated With Poor Prognosis of Pancreatic Adenocarcinoma: Validated Analysis Based on Four Cancer Databases

OBJECTIVE: The aim of this study was to explore the association between the expression of a long non-coding RNA (lncRNA), cancer susceptibility candidate 8 (CASC8), and pancreatic adenocarcinoma (PAAD). MATERIALS AND METHODS: starBase database was used to perform differential expression, survival, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yingyi, Yang, Yuemei, Wang, Yanfeng, Li, Xiaoou, Xiao, Yu, Wang, Wenze
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287184/ https://www.ncbi.nlm.nih.gov/pubmed/32582694 http://dx.doi.org/10.3389/fcell.2020.00392

Ejemplares similares

Five Novel Genes Related to the Pathogenesis and Progression of Pancreatic Neuroendocrine Tumors by Bioinformatics Analysis With RT-qPCR Verification
por: Xiao, Yu, et al.
Publicado: (2019)

Treacle is Upregulated in Cancer and Correlates With Poor Prognosis
por: Oxe, Kezia Catharina, et al.
Publicado: (2022)

CREM Is Correlated With Immune-Suppressive Microenvironment and Predicts Poor Prognosis in Gastric Adenocarcinoma
por: Yu, Kuai, et al.
Publicado: (2021)

Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma
por: Liu, Cong, et al.
Publicado: (2022)

Upregulation of SPP1 Is a Marker for Poor Lung Cancer Prognosis and Contributes to Cancer Progression and Cisplatin Resistance
por: Tang, Huaping, et al.
Publicado: (2021)

Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma
por: Xue, Shengbai, et al.
Publicado: (2022)

TP53 Mutation Infers a Poor Prognosis and Is Correlated to Immunocytes Infiltration in Breast Cancer
por: Zhang, Ziwen, et al.
Publicado: (2021)

Comprehensive Analysis of Glycolysis-Related Genes for Prognosis, Immune Features, and Candidate Drug Development in Colon Cancer
por: Cui, Zhongqi, et al.
Publicado: (2021)

Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer
por: Liu, Dongliang, et al.
Publicado: (2022)

Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients
por: Yue, Taohua, et al.
Publicado: (2021)

Quiescin Sulfhydryl Oxidase 2 Overexpression Predicts Poor Prognosis and Tumor Progression in Patients With Colorectal Cancer: A Study Based on Data Mining and Clinical Verification
por: Jiang, Tao, et al.
Publicado: (2021)

Seven Glycolysis-Related Genes Predict the Prognosis of Patients With Pancreatic Cancer
por: Nie, Han, et al.
Publicado: (2021)

High IER5 Gene Expression Is Associated With Poor Prognosis in Glioma Patients
por: Wu, Zijun, et al.
Publicado: (2021)

Increased ATG5 Expression Predicts Poor Prognosis and Promotes EMT in Cervical Carcinoma
por: Zhou, Suna, et al.
Publicado: (2021)

Corrigendum: Seven Glycolysis-Related Genes Predict the Prognosis of Patients With Pancreatic Cancer
por: Nie, Han, et al.
Publicado: (2021)

Corrigendum: Increased ATG5 Expression Predicts Poor Prognosis and Promotes EMT in Cervical Carcinoma
por: Zhou, Suna, et al.
Publicado: (2022)

A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer
por: Ge, Weiyu, et al.
Publicado: (2022)

Association of Angiogenesis Gene Expression With Cancer Prognosis and Immunotherapy Efficacy
por: Li, Xin-yu, et al.
Publicado: (2022)

A Combined Two-mRNA Signature Associated With PD-L1 and Tumor Mutational Burden for Prognosis of Lung Adenocarcinoma
por: Song, Congkuan, et al.
Publicado: (2021)

Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
por: Hua, Linbin, et al.
Publicado: (2023)

Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma
por: Wu, Huanwen, et al.
Publicado: (2015)

Accurate Prediction of Prognosis by Integrating Clinical and Molecular Characteristics in Colon Cancer
por: Wang, Liru, et al.
Publicado: (2021)

Neddylation pattern indicates tumor microenvironment characterization and predicts prognosis in lung adenocarcinoma
por: Cui, Yuan, et al.
Publicado: (2022)

SUMOylation patterns and signature characterize the tumor microenvironment and predict prognosis in lung adenocarcinoma
por: Chen, Zhike, et al.
Publicado: (2023)

Identification and Validation of Constructing the Prognostic Model With Four DNA Methylation-Driven Genes in Pancreatic Cancer
por: Chen, Guangyu, et al.
Publicado: (2022)

The Expression Pattern of Hypoxia-Related Genes Predicts the Prognosis and Mediates Drug Resistance in Colorectal Cancer
por: Yuan, Ye, et al.
Publicado: (2022)

Identification of an m6A-Related Long Noncoding RNA Risk Model for Predicting Prognosis and Directing Treatments in Patients With Colon Adenocarcinoma
por: Liao, Wanying, et al.
Publicado: (2022)

Genome Instability and Long Noncoding RNA Reveal Biomarkers for Immunotherapy and Prognosis and Novel Competing Endogenous RNA Mechanism in Colon Adenocarcinoma
por: Ren, Ziyuan, et al.
Publicado: (2021)

Identification of N6-Methyladenosine-Associated Long Non-coding RNAs for Immunotherapeutic Response and Prognosis in Patients With Pancreatic Cancer
por: Yu, Xinshuang, et al.
Publicado: (2021)

Comprehensive Analyses of MELK-Associated ceRNA Networks Reveal a Potential Biomarker for Predicting Poor Prognosis and Immunotherapy Efficacy in Hepatocellular Carcinoma
por: Liu, Yu, et al.
Publicado: (2022)

An Immune Panel Signature Predicts Prognosis of Lung Adenocarcinoma Patients and Correlates With Immune Microenvironment
por: Zhou, Yuan, et al.
Publicado: (2021)

Dynamic Changes in Myofibroblasts Affect the Carcinogenesis and Prognosis of Bladder Cancer Associated With Tumor Microenvironment Remodeling
por: Du, YiHeng, et al.
Publicado: (2022)

lncRNA/miR-29c-Mediated High Expression of LOX Can Influence the Immune Status and Chemosensitivity and Can Forecast the Poor Prognosis of Gastric Cancer
por: Nai, Aitao, et al.
Publicado: (2022)

Higher Urine Exosomal miR-193a Is Associated With a Higher Probability of Primary Focal Segmental Glomerulosclerosis and an Increased Risk of Poor Prognosis Among Children With Nephrotic Syndrome
por: Wang, Lixia, et al.
Publicado: (2021)

Identification of CHMP7 as a promising immunobiomarker for immunotherapy and chemotherapy and impact on prognosis of colorectal cancer patients
por: Guo, Yu, et al.
Publicado: (2023)

Identification and Quantification of Iron Metabolism Landscape on Therapy and Prognosis in Bladder Cancer
por: Song, Xiaodong, et al.
Publicado: (2022)

Establishment of a Necroptosis Related Genes Signature to Predict Prognosis and Therapeutic Response in Colon Cancer
por: Wang, Yuan, et al.
Publicado: (2022)

miRNAs in the Diagnosis and Prognosis of Skin Cancer
por: Neagu, Monica, et al.
Publicado: (2020)

RNA 5-Methylcytosine Regulators Contribute to Metabolism Heterogeneity and Predict Prognosis in Ovarian Cancer
por: Xu, Jie, et al.
Publicado: (2022)

Prognosis and Immunotherapy Response With a Novel Golgi Apparatus Signature-Based Formula in Lung Adenocarcinoma
por: Jiang, Yupeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s2j5ooq4iv909eqi2iqltgm7uj